Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Accumulated Depreciation (2016 - 2017)

Bone Biologics (BBLG) has disclosed Accumulated Depreciation for 2 consecutive years, with $309.0 as the latest value for Q2 2017.

  • On a quarterly basis, Accumulated Depreciation changed N/A to $309.0 in Q2 2017 year-over-year; TTM through Jun 2017 was $309.0, a N/A change, with the full-year FY2016 number at $261.0, changed N/A from a year prior.
  • Accumulated Depreciation was $309.0 for Q2 2017 at Bone Biologics, up from $285.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $309.0 in Q2 2017 to a low of $261.0 in Q4 2016.